NEW YORK (GenomeWeb News) — Orchid Cellmark today said third-quarter revenues decreased 4 percent as R&D spending declined 16 percent and losses fell 65 percent.
Total receipts for the three months ended Sept. 30 decreased to $15.7 million from $16.4 million year over year.
R&D spending decreased to $316,000 from $376,000 year over year.
The company said losses declined to $1.3 million from $3.8 million in the year-ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.